Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial
Titel:
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial
Auteur:
Caimi, Paolo F Ai, Weiyun Alderuccio, Juan Pablo Ardeshna, Kirit M Hamadani, Mehdi Hess, Brian Kahl, Brad S Radford, John Solh, Melhem Stathis, Anastasios Zinzani, Pier Luigi Havenith, Karin Feingold, Jay He, Shui Qin, Yajuan Ungar, David Zhang, Xiaoyan Carlo-Stella, Carmelo